RETRACTED ARTICLE: A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells

Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in Vivo

Jacqueline W. Pierce, Robert Schoenleber, Gary Jesmok et al. · Journal of Biological Chemistry · 1997 · 1.1K citations · Full text

Life Sciences, Immunology, Pharmacology +17

Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

Kiwon Ban, M. Hossein Noyan-Ashraf, Judith Hoefer et al. · Circulation · 2008 · 1K citations

Medicine, Cardiology, Pharmacology +17

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.

Bernard Thorens · Proceedings of the National Academy of Sciences · 1992 · 905 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease

Thomas Nyström, M. Gutniak, Qimin Zhang et al. · American Journal of Physiology-Endocrinology and Metabolism · 2004 · 671 citations

Medicine, Cardiology, Endocrinology +17

GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice

M. Hossein Noyan-Ashraf, M. Abdul Momen, Kiwon Ban et al. · Diabetes · 2009 · 572 citations · Full text

Medicine, Endocrinology, Pharmacology +17